Short Interest In Progenics Pharmaceuticals Increases 14.8%

The most recent short interest data has been released by the NASDAQ for the 07/31/2014 settlement date, which shows a 1,125,393 share increase in total short interest for Progenics Pharmaceuticals, Inc. (PGNX), to 8,716,444, an increase of 14.83% since 07/15/2014..
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.